US 10730949
Method of treating PVNS with anti-CSF1R antibodies
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10730949 (Method of treating PVNS with anti-CSF1R antibodies) held by Five Prime Therapeutics, Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P19/02